PL2377550T3 - Bakteryny poddane obróbce cieplnej oraz szczepionki emulsyjne wytworzone z takich bakteryn poddanych obróbce cieplnej - Google Patents

Bakteryny poddane obróbce cieplnej oraz szczepionki emulsyjne wytworzone z takich bakteryn poddanych obróbce cieplnej

Info

Publication number
PL2377550T3
PL2377550T3 PL11173797T PL11173797T PL2377550T3 PL 2377550 T3 PL2377550 T3 PL 2377550T3 PL 11173797 T PL11173797 T PL 11173797T PL 11173797 T PL11173797 T PL 11173797T PL 2377550 T3 PL2377550 T3 PL 2377550T3
Authority
PL
Poland
Prior art keywords
heat treated
treated bacterins
bacterins
vaccines prepared
emulsion vaccines
Prior art date
Application number
PL11173797T
Other languages
English (en)
Inventor
Mark Davis Goodyear
Michael John Huether
Ramasamy Mannar Mannan
Nancee Lois Oien
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of PL2377550T3 publication Critical patent/PL2377550T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL11173797T 2006-09-11 2007-08-30 Bakteryny poddane obróbce cieplnej oraz szczepionki emulsyjne wytworzone z takich bakteryn poddanych obróbce cieplnej PL2377550T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84366506P 2006-09-11 2006-09-11
EP07804880.8A EP2066340B1 (en) 2006-09-11 2007-08-30 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
EP11173797.9A EP2377550B1 (en) 2006-09-11 2007-08-30 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins

Publications (1)

Publication Number Publication Date
PL2377550T3 true PL2377550T3 (pl) 2015-07-31

Family

ID=39110574

Family Applications (2)

Application Number Title Priority Date Filing Date
PL11173797T PL2377550T3 (pl) 2006-09-11 2007-08-30 Bakteryny poddane obróbce cieplnej oraz szczepionki emulsyjne wytworzone z takich bakteryn poddanych obróbce cieplnej
PL07804880T PL2066340T3 (pl) 2006-09-11 2007-08-30 Bakteryny poddane obróbce cieplnej oraz szczepionki emulsyjne z takich bakteryn poddanych obróbce cieplnej

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL07804880T PL2066340T3 (pl) 2006-09-11 2007-08-30 Bakteryny poddane obróbce cieplnej oraz szczepionki emulsyjne z takich bakteryn poddanych obróbce cieplnej

Country Status (27)

Country Link
US (1) US8491915B2 (pl)
EP (2) EP2377550B1 (pl)
JP (2) JP5550341B2 (pl)
KR (1) KR101238486B1 (pl)
CN (1) CN101516393B (pl)
AR (1) AR062758A1 (pl)
AU (1) AU2007297287B2 (pl)
BR (1) BRPI0716548B1 (pl)
CA (1) CA2663166C (pl)
CL (1) CL2007002621A1 (pl)
CO (1) CO6160333A2 (pl)
DK (2) DK2066340T3 (pl)
ES (2) ES2432392T3 (pl)
HK (1) HK1130202A1 (pl)
ME (1) ME00598B (pl)
MX (1) MX2009001849A (pl)
NO (1) NO339147B1 (pl)
NZ (2) NZ574896A (pl)
PL (2) PL2377550T3 (pl)
PT (1) PT2066340E (pl)
RS (1) RS54981B1 (pl)
RU (2) RU2425692C2 (pl)
SI (1) SI2066340T1 (pl)
TW (1) TWI361077B (pl)
UA (1) UA98115C2 (pl)
WO (1) WO2008032158A2 (pl)
ZA (1) ZA200902493B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009090461A1 (en) * 2007-12-21 2009-07-23 Pfizer Inc. Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
EP2717055A1 (en) * 2012-10-04 2014-04-09 Institut Pasteur Use of Leptospira fainei serovar Hurstbridge bacteria for diagnosing leptospirosis
JP2024510057A (ja) * 2020-05-26 2024-03-06 サイラス トェンティファースト センチュリー アントレプレナーシップ エルエルシー ハキムプールシナの除染手順

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3721169A1 (de) * 1986-06-30 1988-01-14 Lion Corp Orale zubereitung
US5084269A (en) 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
AU2001234616A1 (en) 2000-01-31 2001-08-07 Vic Jira Vaccine composition, process and methods
US20030147914A1 (en) 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
CA2496750C (en) 2002-08-26 2014-10-21 Pfizer Products Inc. Vaccine for respiratory and reproductive system infections in cattle
EP1549135A4 (en) 2002-09-20 2006-01-11 Us Agriculture VACCINE AND ADJUVANT COMPOSITIONS
AU2002951692A0 (en) 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
KR20050103215A (ko) * 2003-01-29 2005-10-27 화이자 프로덕츠 인코포레이티드 보르데텔라 브론키셉티카에 대한 개 백신
PT1613346E (pt) * 2003-04-04 2013-01-29 Pah Usa 15 Llc Emulsões óleo-em-água microfluidificadas e composições de vacinas

Also Published As

Publication number Publication date
MEP7509A (en) 2011-12-20
US20080112970A1 (en) 2008-05-15
DK2377550T3 (en) 2015-04-07
NZ595748A (en) 2013-07-26
RS54981B1 (sr) 2016-11-30
KR101238486B1 (ko) 2013-03-04
JP2014088428A (ja) 2014-05-15
RU2569457C2 (ru) 2015-11-27
RU2009108004A (ru) 2010-10-20
AU2007297287B2 (en) 2013-03-14
CO6160333A2 (es) 2010-05-20
ES2432392T3 (es) 2013-12-03
ES2535977T3 (es) 2015-05-19
WO2008032158A2 (en) 2008-03-20
SI2066340T1 (sl) 2013-11-29
EP2066340B1 (en) 2013-07-31
RU2425692C2 (ru) 2011-08-10
PT2066340E (pt) 2013-10-30
CL2007002621A1 (es) 2008-03-14
EP2377550B1 (en) 2015-03-04
TWI361077B (en) 2012-04-01
JP5643906B2 (ja) 2014-12-17
KR20090039840A (ko) 2009-04-22
ZA200902493B (en) 2010-03-31
JP5550341B2 (ja) 2014-07-16
CA2663166C (en) 2015-11-03
US8491915B2 (en) 2013-07-23
CN101516393A (zh) 2009-08-26
EP2066340A2 (en) 2009-06-10
DK2066340T3 (da) 2013-10-14
JP2010502238A (ja) 2010-01-28
UA98115C2 (ru) 2012-04-25
NZ574896A (en) 2011-11-25
NO339147B1 (no) 2016-11-14
MX2009001849A (es) 2009-03-02
PL2066340T3 (pl) 2013-12-31
HK1130202A1 (en) 2009-12-24
AR062758A1 (es) 2008-12-03
TW200820990A (en) 2008-05-16
EP2377550A1 (en) 2011-10-19
NO20090745L (no) 2009-03-11
CA2663166A1 (en) 2008-03-20
AU2007297287A1 (en) 2008-03-20
ME00598B (me) 2011-12-20
BRPI0716548B1 (pt) 2020-10-06
BRPI0716548A2 (pt) 2013-09-24
CN101516393B (zh) 2014-05-14
RU2011115400A (ru) 2012-10-27
WO2008032158A3 (en) 2008-07-03
RS20090088A (en) 2010-06-30

Similar Documents

Publication Publication Date Title
ZA201005178B (en) Heat treated bacterins,and emulsion vaccines prepared from such heat treated bacterins
EP1987298A4 (en) DEVICE AND METHOD FOR HEATING AND / OR COOLING
EP2049559A4 (en) IMPROVED VACCINES AND METHOD FOR THEIR USE
EP1751478A4 (en) THERMAL TREATMENT SYSTEM FOR HOT GAS
EP2035857A4 (en) METHOD AND MISSILE SYSTEM
EP2015256A4 (en) DRAWING DEVICE AND DRAWING METHOD
EP1984405A4 (en) INFLUENZA ANTIGENS, VACCINE COMPOSITIONS AND ASSOCIATED METHODS
HK1128614A1 (en) Anti-amyloid immunogenic compositions, methods and uses
PL2578081T4 (pl) Kompozycje, sposoby i urządzenia do leczenia chorób wątroby
IL193397A0 (en) Hpv antigens, vaccine compositions, and related methods
EP2075515A4 (en) HEAT SOURCE DEVICE, HEAT SOURCE SYSTEM, AND HEAT SOURCE DEVICE CONTROL METHOD
EP2085722A4 (en) HEAT SOURCE DEVICE, HEAT SOURCE SYSTEM, AND METHOD OF OPERATING THE HEAT SOURCE DEVICE
TWI371777B (en) Heat treatment unit, heat treatment method, and computer-readable recording medium
EP1934536A4 (en) THERMOELECTRIC HEAT PUMP FOR VENTILATION OF HEAT AND ENERGY RECOVERY
IL193643A0 (en) Metal heat treating methods and devices
GB0723711D0 (en) Heat recovery system and method
HK1130202A1 (en) Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
HK1118893A1 (en) Heat pump and method of operating heat pump
EP2058409A4 (en) HEAT TREATMENT PROCESS
TWI339936B (en) Fan system and starting method thereof
GB0607562D0 (en) Method, composition and use
EP2142160A4 (en) METHOD FOR HEATING A SAUNA OVEN AND SAUNA OVEN
PL1842931T3 (pl) Sposób obróbki cieplnej
PL381254A1 (pl) Sposób oświetlania i/lub ogrzewania, urządzenie do oświetlania i/lub ogrzewania, zestaw do oświetlania i/lub ogrzewania
SI1996705T1 (sl) Ekspresijo povečevalni DNA fragmenti, njihova uporaba in postopki za njihovo odkrivanje